Metformin as an adjuvant option for systemic treatment of breast cancer
The modification of the used and development of new treatment regimens significantly improved the overall, recurrence-free survival and quality of life of patients with malignant oncological diseases. Recently, drugs used in non-oncological pathology have been introduced into cancer treatment regim...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dnipro State Medical University
2023-12-01
|
| Serija: | Medičnì Perspektivi |
| Teme: | |
| Online pristup: | https://journals.uran.ua/index.php/2307-0404/article/view/294154 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|